A biotech based out of New York found a tremendous amount of success on Tuesday after the company announced new clinical data from the ongoing Phase 1 investigator-sponsored trial...

To read the full story on AllPennyStocks.com, click here.

IN8bio (NASDAQ:INAB)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse IN8bio
IN8bio (NASDAQ:INAB)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse IN8bio